The recent dip in Bitcoin (BTC) below $105,500, as the crypto market pauses ahead of the U.S. Federal Reserve’s interest rate decision, has not directly impacted the health-tech sector’s IPO rush in 2025, but broader market dynamics provide context. India’s health-tech industry is experiencing a significant surge in initial public offerings (IPOs), driven by digitization, supportive government policies, and AI adoption. Since January 2024, five out of 12 healthcare IPOs in India were health-tech companies—Entero Healthcare Solutions, Indegene, Sagility India, Sai Life Sciences, and Inventurus Knowledge Solutions—collectively raising over ₹11,000 crore out of a total ₹20,576 crore.
The post-pandemic emphasis on digital health infrastructure, exemplified by initiatives like e-Sanjeevani, has boosted investor interest in telemedicine, diagnostics, and health data solutions. AI’s growing role in diagnostics and personalized treatment, coupled with government reforms easing market access, has further fueled this trend. Companies like QubeHealth, Vitraya, Practo, and Medulance are preparing for future IPOs. Influx Healthtech’s IPO, for instance, saw strong demand, booked three times on its first day with a grey market premium of 47%.
Globally, digital health funding rebounded to $25.1 billion in 2024, with AI capturing 58% of venture funding, signaling strong investor confidence. In the U.S., health-tech firms like Omada Health and Hinge Health, which debuted with a 17% share jump, are leading IPO activity, supported by AI-driven innovations and regulatory clarity. However, the crypto market’s volatility, influenced by geopolitical tensions and Fed decisions, could indirectly affect investor sentiment toward high-growth sectors like health-tech if macroeconomic conditions tighten. Despite this, the sector’s resilience, driven by proven ROI and scalable solutions, positions it for continued growth in 2025.